IMMY买入原因:今天IMMY发的干眼症药物为Restasis的仿制药,RESTASIS 2016年第三季度全球销售额为371.6million, 第四季度全球销售额393.1 million占干眼症市场的80%,现有竞争对手仅有Shire’s idra,占20%的市场。IMMY的仿制药由于是走低价路线,有可...查看全文
TLS美股研究2017-04-09 21:31
回复@panderson: $IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 我们看看。我刚打赏了这条评论 ¥2.88,也推荐给你。//@panderson:回复@TLS美股研究:IMMY值得关注,眼科市场天花板逐渐打开,公司高管参与增发,市值迷你,会是小黑马吗 查看全文
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-05-10 AccNo: 0001493152-17-004968 Size: 3 MB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2017-05-10 AccNo: 0001493152-17-004958 Size: 86 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 美东时间 2017-05-10 盘后 披露财报,预期EPS -0.19 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2017-05-02 AccNo: 0001493152-17-004662 Size: 203 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ DEF 14A - Other definitive proxy statements Filed: 2017-04-27 AccNo: 0001493152-17-004479 Size: 958 KB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-04-19 AccNo: 0001144204-17-021070 Size: 43 KB 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2017-04-17 AccNo: 0001493152-17-004045 Size: 28 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers http...
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2017-04-17 AccNo: 0001493152-17-004007 Size: 150 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ 8-K - Current report Filed: 2017-04-06 AccNo: 0001493152-17-003596 Size: 150 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$IMPRIMIS PHARMACEUTICALS INC(IMMY)$ SC 13G - Statement of acquisition of beneficial ownership by individuals Filed: 2017-03-29 AccNo: 0001144204-17-017136 Size: 44 KB 网页链接